Drug
bimatoprost vehicle solution
bimatoprost vehicle solution is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
100%(5 trials)
Phase Distribution
Ph phase_3
2
40%
Ph phase_4
1
20%
Ph phase_2
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis
NCT01391273
completedphase_3
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis
NCT01391286
completedphase_2
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
NCT01325337
completedphase_2
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
NCT01325350
completedphase_4
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
NCT01448525
Clinical Trials (5)
Showing 5 of 5 trials
NCT01391273Phase 3
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis
NCT01391286Phase 3
Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis
NCT01325337Phase 2
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
NCT01325350Phase 2
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
NCT01448525Phase 4
Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5